Sunday, July 27, 2014

Top 5 Japanese Companies To Watch In Right Now

Stocks went nowhere today after making back early losses, as Chevron (CVX) and Wal-Mart (WMT) gained, while Visa (V) and Boeing (BA) fell.

REUTERS

The S&P 500 gained 0.03% to 1,868.20, while the Dow Jones Industrial Average fell 0.07% to 16,340.08. Chevron’s 1% gain, which came after being added to the Focus List at Credit Suisse, and Wal-Mart’s 0.8% rise helped balance out�Visa’s 0.5% fall and� Boeing’s 1% drop, which came after UBS cut its price target. Tesoro (TSO) jumped 4.1% to $54.50 after oil prices fell, making the refiner the S&P 500′s biggest winner.

Once again, concerns about China are reputed to have driven early weakness in the stock market. Rhino Trading Partners’ Michael Block expresses his concern about the falling Chinese yuan:

…cheaper Chinese exports could wreak havoc on non Chinese exporters around the world.� The most obvious losers would be South Korean, Japanese, U.S. and European stocks that are heavy exporters to countries other than China…In the U.S., I am concerned about export heavy sectors like autos and steel the most.� Given the weaker yuan and lower Chinese purchasing power, consumer companies selling into China, whether they be luxury goods makers or QSRs, are also ones to avoid here.

Top 5 Consumer Companies To Buy For 2015: Black Hills Corporation (BKH)

Black Hills Corporation, together with its subsidiaries, operates as a diversified energy company in the United States. The company’s Electric Utilities segment generates, transmits, and distributes electricity to approximately 202,000 electric customers in South Dakota, Wyoming, Colorado, and Montana; and distributes natural gas to approximately 35,000 gas utility customers in Cheyenne, Wyoming. It owns 859 Megawatts of generation capacity and 8,530 miles of electric transmission and distribution lines. The company’s Gas Utilities segment distributes natural gas to approximately 532,000 natural gas utility customers in Colorado, Nebraska, Iowa, and Kansas. It owns 624 miles of intrastate gas transmission pipelines and 19,979 miles of gas distribution mains and service lines. The company’s Oil and Gas segment is involved in the acquisition, exploration, development, and production of crude oil and natural gas primarily in the Rocky Mountain region. This s egment’s principal assets include the operating interests in the properties in the San Juan basin, the Powder River basin, and the Piceance basin; and non-operated interests in wells located in the Williston, Wind River, Bear Paw Uplift, Arkoma, Anadarko, and Sacramento basins. As of December 31, 2012, it had total reserves of approximately 81 billion cubic feet equivalent of natural gas and crude oil. The company’s Power Generation segment produces electric power and sells the electric capacity and energy primarily to other utilities under long-term contracts. Its Coal Mining segment produces coal at its coal mine located near Gillette, Wyoming. The company also provides appliance repair services to approximately 62,000 residential customers; and constructs gas infrastructure facilities for gas transportation customers. Black Hills Corporation was founded in 1941 and is headquartered in Rapid City, South Dakota.

Advisors' Opinion:
  • [By Marc Bastow]

    Diversified energy company Black Hills (BKH) raised its quarterly dividend 2.6% to 39 cents per share, payable on Mar. 1 to shareholders of record as of Feb. 14. This is the 44th consecutive annual dividend increase, proving why utilities make such consistent dividend stocks.
    BKH Dividend Yield: 2.84%

  • [By Laura Brodbeck]

    Monday

    Earnings Releases Expected: Black Hills Corporation (NYSE: BKH), CME Group Inc. (NASDAQ: CME), Leapfrog Enterprises (NYSE: LF), Hill International, Inc. (NYSE: HIL) Economic Releases Expected: eurozone manufacturing PMI, British construction PMI, US factory orders, Chinese services PMI, Indian services PMI

    Tuesday

Top 5 Japanese Companies To Watch In Right Now: Ishares Msci Switzerland (EWL)

iShares MSCI Switzerland Index Fund (the Fund) seeks to provide investment results that correspond generally to the price and yield performance of publicly traded securities in the aggregate in the Swiss market, as measured by the MSCI Switzerland Index (the Index). The Index seeks to measure the performance of the Swiss equity market. The Index is a capitalization-weighted index that aims to capture 85% of the (publicly available) total market capitalization. Component companies are adjusted for available float and must meet objective criteria for inclusion in the Index. The Index is reviewed quarterly.

The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. The Fund�� investment advisor is Barclays Global Fund Advisors.

Advisors' Opinion:
  • [By Carlton Delfeld]

    The iShares Switzerland (EWL) is a wonderful way to gain exposure to a basket of Switzerland's leading multinationals and has an expense ratio of only 0.59%. In addition, while a rising Swiss franc puts pricing pressure on Swiss exporters, a strong Swiss franc supercharges returns for investors in EWL.

  • [By Mark Salzinger]

    iShares MSCI Germany (EWG) and iShares MSCI Switzerland (EWL) continue to have relatively attractive valuations.

    EWG recently sported an average price/earnings (P/E) ratio on 2013's projected earnings of 12.6 and a price/book value (P/B) of just 1.4.

Top 5 Japanese Companies To Watch In Right Now: Five Prime Therapeutics Inc (FPRX)

Five Prime Therapeutics, Inc., incorporated on December 20, 2001, is a clinical-stage biotechnology company focused on discovering and developing protein therapeutics. Protein therapeutics is antibodies or drugs developed from extracellular proteins or protein fragments that block disease processes, including cancer and inflammatory diseases. The Company�� advanced product candidates include FP-1039/GSK3052230 (FP-1039), FPA008 and FPA144. FP-1039 is a protein therapeutic that traps and neutralizes cancer-promoting fibroblast growth factors (FGFs), involved in cancer cell proliferation and new blood vessel formation. FPA008 is an antibody that inhibits colony stimulating factor-1 receptor (CSF1R), and is being developed to treat patients with inflammatory diseases, including rheumatoid arthritis (RA). FPA144 is an antibody that inhibits FGF receptor 2b (FGFR2b), and is being developed to treat patients with gastric cancer and potentially other solid tumors.

FP-1039

FP-1039 is a protein therapeutic, which includes the extracellular part of FGFR1. FP-1039 acts as an inhibitor of FGFs, because the FGFR1 portion of the molecule binds to FGFs and prevents them from binding to FGFR1 on tumor and blood vessel cells. Because FGF proteins circulating in the blood are called ligands, FP-1039 is called a ligand trap. FP-1039 also includes a portion of an antibody called the Fc region. In preclinical testing, it observed inhibition of tumor growth with single-agent FP-1039, particularly in tumors withFGFR1 gene amplification, including squamous NSCLC and SCLC.

FPA008

FPA008 is an antibody that inhibits CSF1R and is being developed to treat patients with RA. FPA008 also has the potential to treat patients with other inflammatory diseases, including lupus nephritis, psoriatic arthritis, ankylosing spondylitis, fibrosis, inflammatory bowel disease and multiple sclerosis. These are chronic, incurable disorders with serious medical complications and disability for ! which better therapies with novel mechanisms of action are needed. FPA008 is an anti-CSF1R antibody, which it designed to block the ability of IL-34 and CSF1 to bind to and activate CSF1R. FPA008 reduces the numbers and activity of monocytes and macrophages that cause disease, and prevents the production and release of inflammatory factors. The Company and others has demonstrated that both IL-34 and CSF1 are present at increased levels in the inflamed joints of patients with RA.

FPA144

FPA144 is a monoclonal antibody directed against a form of FGFR2, or FGFR2b. When the FGFR2 gene is amplified by cancer cells, the FGFR2b protein is expressed at abnormally high levels on the tumor�� surface. This occurs in some patients with gastric and lower esophageal cancers. The tumor cells that have too much FGFR2b protein on their surface can be identified by special staining tests performed on the tumor. Because FGFR2b is the target for FPA144, patients��tumors can be screened for this protein, helping to identify the patients most likely to respond to FPA144 treatment.

Advisors' Opinion:
  • [By Monica Gerson]

    Breaking news

    Alcoa (NYSE: AA) is investing US$13 million to expand its wheel manufacturing plant in Europe, to meet growing demand for its lightweight, durable, low-maintenance aluminum truck wheels. To read the full news, click here. L & L Energy (NASDAQ: LLEN) announced today that its Special Independent Committee has appointed Mr. Nicholas Chen, Managing Partner at Pamir Law Group, to replace Mr. Mark Bartlett. To read the full news, click here. Five Prime Therapeutics (NASDAQ: FPRX) and Bristol-Myers Squibb (NYSE: BMY) announced today that they have signed a collaboration agreement for the discovery, development and commercialization of immuno-oncology therapies directed toward targets identified in two undisclosed immune checkpoint pathways using Five Prime's proprietary target discovery platform. To read the full news, click here. First Solar (NASDAQ: FSLR) on Sunday announced the completion of the 1.3MW(DC) solar photovoltaic (PV) power plant at Kitakyushu-shi. Powered by First Solar FS Series 3 Black PV modules, the plant will generate approximately 1,400 MWh of clean and safe solar electricity per year. To read the full news, click here.

    Posted-In: Credit Suisse US Stock FuturesNews Eurozone Futures Global Pre-Market Outlook Markets

  • [By John Kell and Tess Stynes var popups = dojo.query(".socialByline .popC"); p]

    Among the companies with shares expected to actively trade in Monday’s session are Keurig Green Mountain Inc.(GMCR), JA Solar Holdings Co.(JASO) and Five Prime Therapeutics Inc.(FPRX)

Top 5 Japanese Companies To Watch In Right Now: Digital Cinema Destinations Corp (DCIN)

Digital Cinema Destinations Corp., incorporated on July 29, 2010, operates eight theatres and 73 screens located in Westfield, New Jersey (Rialto), Cranford, New Jersey (Cranford), Bloomfield, Connecticut (the Bloomfield 8) and five theatres located in central Pennsylvania (Cinema Centers). During the fiscal year ended June 30, 2012 (fiscal 2012), the Company operates eight theatres, two in New Jersey, with a total of 11 screens, one in Connecticut, with a total of 8 screens and five in central Pennsylvania, with a total of 54 screens. In March 2014, the Company announced that it has completed the acquisition of a seven screen theater in Churchville, MD from Flagship Cinemas.

The Rialto is a six-screen theatre located in downtown Westfield, New Jersey, which has a population of approximately 30,000 people. The Bloomfield 8 is an eight-screen theatre located at the Wintonbury Mall in the town of Bloomfield, Connecticut, which is a New England town of over 20,000 people that is home to many sites that are on the National Register of Historic Places and is approximately 5.5 miles from downtown Hartford, Connecticut. Cinema Centers consists of a chain of five theatres with 54 screens located throughout central Pennsylvania. All of the Cinema Centers theatres are in free zones. The 11-screen Cinema Center of Bloomsburg theatre is located in Bloomsburg, Pennsylvania. Bloomsburg, a college town of approximately 13,000 people, is located midway between Wilkes Barre and Williamsport, Pennsylvania. The 12-screen Cinema Center of Camp Hill theatre is located in Camp Hill, Pennsylvania, just outside of Harrisburg, Pennsylvania. Harrisburg is the state capital of Pennsylvania with a population of approximately 50,000 people.

The 10-screen Cinema Center at Fairgrounds Square Mall is located in Reading, Pennsylvania. The Company�� Cinema Centers, had one digital projector, RealD 3D enabled. The 12-screen Cinema Center at Selinsgrove is located in Selinsgove, Pennsylvania. Selinsgrove is ! a historic town located on the Susquehanna River with a population of approximately 27,000 people located within five miles of the theatre. The nine-screen Cinema Center of Williamsport is located in Williamsport, Pennsylvania.

The Company competes with Regal Entertainment Group, AMC Entertainment Inc., Clearview and Cinemark USA, Inc.

Advisors' Opinion:
  • [By Erin McCarthy]

    Carmike Cinemas Inc.(CKEC), the nation’s fourth-largest movie theater chain, said Thursday it is acquiring Digital Cinema Destinations Corp.(DCIN), a smaller rival that does business as Digiplex.

No comments:

Post a Comment